Conference Calendar - The 88th EAS Congress

All times are in CET (Central European Time)

Displaying One Session

View

Plenary

UNDERSTANDING BIOLOGY FOR CLINICAL APPLICATION

Session Type

Plenary

Chair(s)

Alberico Luigi Catapano, Italy

Room

Hall 1

Date

06.10.2020, Tuesday

Session Time

08:30 - 09:53

Session Ticket

Session Evaluation

Option 1

Watch Stream
Session Webcast

Session Webcast

[{"name":"Introduction","mode":"playlist","public":true,"info":{"id":1551,"presentation":"Introduction","session":"UNDERSTANDING BIOLOGY FOR CLINICAL APPLICATION","presenter":"Alberico Luigi Catapano, Italy","photo":""},"playlist":[{"name":"1551-Introduction","source":"https:\/\/s3.eu-central-1.amazonaws.com\/eu-cslide-prod-recordings\/eas20\/19\/EAS201551.mp4","source_path":"s3:\/\/eu-cslide-prod-recordings\/eas20\/19\/EAS201551.mp4","cover":"https:\/\/s3.eu-central-1.amazonaws.com\/eu-cslide-prod-recordings\/eas20\/19\/9235A32A.jpg","data":[],"tracks":[]}]},{"name":"The lipoprotein(a) story - from risk factor to causality to clinical trials","mode":"playlist","public":true,"info":{"id":1440,"presentation":"The lipoprotein(a) story - from risk factor to causality to clinical trials","session":"UNDERSTANDING BIOLOGY FOR CLINICAL APPLICATION","presenter":"Sotirios Tsimikas, United States of America","photo":"https:\/\/cslide.ctimeetingtech.com\/global_storage\/media\/content\/eas20\/persons\/photos\/5288.jpg"},"playlist":[{"name":"","source":"https:\/\/s3.eu-central-1.amazonaws.com\/eu-cslide-prod-recordings\/eas20\/19\/Dr. Sotirios Sam Tsimikas - EAS20- 1440 -The lipoprotein(a) story - from risk factor to causality to clinical trials.mp4","source_path":"s3:\/\/eu-cslide-prod-recordings\/eas20\/19\/Dr. Sotirios Sam Tsimikas - EAS20- 1440 -The lipoprotein(a) story - from risk factor to causality to clinical trials.mp4","cover":"https:\/\/s3.eu-central-1.amazonaws.com\/eu-cslide-prod-recordings\/eas20\/19\/491E1C2.jpg","data":[],"tracks":[]}]},{"name":"Immune modulation in atherosclerosis","mode":"playlist","public":true,"info":{"id":1441,"presentation":"Immune modulation in atherosclerosis","session":"UNDERSTANDING BIOLOGY FOR CLINICAL APPLICATION","presenter":"Ziad Mallat, United Kingdom","photo":""},"playlist":[{"name":"","source":"https:\/\/s3.eu-central-1.amazonaws.com\/eu-cslide-prod-recordings\/eas20\/19\/Ziad Mallat - EAS20 - 1441 - Immune modulation in atherosclerosis.mp4","source_path":"s3:\/\/eu-cslide-prod-recordings\/eas20\/19\/Ziad Mallat - EAS20 - 1441 - Immune modulation in atherosclerosis.mp4","cover":"https:\/\/s3.eu-central-1.amazonaws.com\/eu-cslide-prod-recordings\/eas20\/19\/1EEE01A7.jpg","data":[],"tracks":[]}]},{"name":"Prevention of cardiovascular diseases by glucose lowering drugs","mode":"playlist","public":true,"info":{"id":1442,"presentation":"Prevention of cardiovascular diseases by glucose lowering drugs","session":"UNDERSTANDING BIOLOGY FOR CLINICAL APPLICATION","presenter":"Stefano Del Prato, Italy","photo":"https:\/\/cslide.ctimeetingtech.com\/global_storage\/media\/content\/eas20\/persons\/photos\/5316.jpg"},"playlist":[{"name":"","source":"https:\/\/s3.eu-central-1.amazonaws.com\/eu-cslide-prod-recordings\/eas20\/19\/Stefano Del Prato - EAS20 - 1442 - Prevention of cardiovascular diseases by glucose lowering drugs.mp4","source_path":"s3:\/\/eu-cslide-prod-recordings\/eas20\/19\/Stefano Del Prato - EAS20 - 1442 - Prevention of cardiovascular diseases by glucose lowering drugs.mp4","cover":"https:\/\/s3.eu-central-1.amazonaws.com\/eu-cslide-prod-recordings\/eas20\/19\/9713E339.jpg","data":[],"tracks":[]}]},{"name":"Will non-coding RNAs change our understanding of vascular biology and disease?","mode":"playlist","public":true,"info":{"id":1443,"presentation":"Will non-coding RNAs change our understanding of vascular biology and disease?","session":"UNDERSTANDING BIOLOGY FOR CLINICAL APPLICATION","presenter":"Stephanie Dimmeler, Germany","photo":""},"playlist":[{"name":"","source":"https:\/\/s3.eu-central-1.amazonaws.com\/eu-cslide-prod-recordings\/eas20\/19\/Prof. Dr. Stefanie Dimmeler - EAS20 - 1443 - Will non-coding RNAs change our understanding of vascular biology and disease.mp4","source_path":"s3:\/\/eu-cslide-prod-recordings\/eas20\/19\/Prof. Dr. Stefanie Dimmeler - EAS20 - 1443 - Will non-coding RNAs change our understanding of vascular biology and disease.mp4","cover":"https:\/\/s3.eu-central-1.amazonaws.com\/eu-cslide-prod-recordings\/eas20\/19\/990A4258.jpg","data":[],"tracks":[]}]}]